Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2->Node(+)>

---

Breast Cancer>HR+>HER2->Node(+)>'s subsections
(*) USA Approval Date: 2021. 10.13
>EBC>Ki-67>20%>Treat>CDK4/6 Inh.>
Company
Generic Name: abemaciclib
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 10.12
RTM
RTM Web-Site

Breast Cancer>HR+>HER2->Node(+)>'s products
This section has no products